Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|June 15, 2017
A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal CancersSung-Yup Cho, Jee Yun Han, Deukchae Na, et al.
Cancer Letters|October 17, 2020
Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancersYumi Oh, Hae Rim Jung, Seoyeon Min, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal CancersSung-Yup Cho, Jeesoo Chae, Deukchae Na, et al.
Frontiers in Pharmacology|August 21, 2019
Gomisin M2 Inhibits Mast Cell-Mediated Allergic Inflammation via Attenuation of FcεRI-Mediated Lyn and Fyn Activation and Intracellular Calcium LevelsHima Dhakal, Soyoung Lee, Eun-Nam Kim, et al.
Oncogene|April 13, 2021
CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancersHae Rim Jung, Yumi Oh, Deukchae Na, et al.
Plos Pathogens|June 22, 2012
Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virusJaehyuk Yoo, Ha Neul Lee, Inho Choi, et al.
British Journal of Cancer|December 15, 2022
An integrative approach for exploring the nature of fibroepithelial neoplasmsJihui Yun, Woohang Heo, Eun-Shin Lee, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Discovery of a potent anti-Zika virus benzamide series targeting the viral protein NS4BDonghoon Chung, Yuka Otsuka, Eunjung Kim, et al.
Plos Pathogens|April 3, 2026
Discovery of a potent anti-Zika virus benzamide series targeting the viral protein NS4BDonghoon Chung, Yuka Otsuka, Eunjung Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2015
Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancerHansoo Park, Sung-Yup Cho, Hyerim Kim, et al.
Pageof 4